We prioritise issues that may:
- Have adverse health consequences for consumers as a result of public access to dangerous or inappropriate goods,
- Affect confidence in our regulatory processes or contribute to a loss of confidence in therapeutic goods in Australia.
All complaints received by the TGA are carefully prioritised. We value all information about cases of potential non-compliance and regularly adjust our strategies for prioritisation in response to new information or trends.
We take a risk-based approach to complaints which is consistent with our approach to regulating therapeutic goods. The actions we take reflect the likely risks associated with non-compliance.